By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Illumina this week said that Macrogen, a Korea-based sequencing services firm, has purchased an additional 10 HiSeq 2000 systems and two MiSeq systems, in addition to upgrades for its HiSeq 2500. Macrogen also intends to develop diagnostic tests based on the MiSeq platform.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Chan Zuckerberg Initiative is investing in Cold Spring Harbor Laboratory's BioRxiv.

A study appearing in PLOS One finds that shortened consent forms don't affect clinical trial participants' understanding of the study.

The National Security Agency monitored signal intelligence for signs of "nefarious" genetic engineering projects, Gizmodo reports.

In Nature this week: barley genome sequenced, method for genotyping and phasing short tandem repeats, and more.